Genextra S.p.A. 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed May 15, 2020
Insider Transaction Report
Form 4
Genextra S.p.A.
10% Owner
Transactions
- Sale
Common stock, par value $0.001 per share
2020-05-13$84.60/sh−595,578$50,385,899→ 5,500,000 total
Footnotes (1)
- [F1]Genextra S.p.A. will apply the proceeds from the sale to reduce outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.